Case-control study of increased mammographic breast density response to hormone replacement therapy

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 11, 2002, Pages 1382-1388

  Vachon, Celine M ^a,b   Sellers, Thomas A ^a,b   Vierkant, Robert A ^a,b   Wu, Fang Fang ^a   Brandt, Kathleen R ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

AGE; ARTICLE; BODY DENSITY; BODY WEIGHT; BREAST BIOPSY; BREAST CANCER; CANCER RISK; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; DENSITY GRADIENT; DRUG USE; FAMILY HISTORY; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MENOPAUSE; PARITY; PRIORITY JOURNAL; RISK FACTOR; SCREENING; UNITED STATES;

AGED; BODY WEIGHT; BREAST; BREAST DISEASES; CASE-CONTROL STUDIES; DRUG THERAPY, COMBINATION; ESTROGENS; FAMILY HEALTH; FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; MAMMOGRAPHY; MINNESOTA; PROGESTINS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STATISTICS; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 0036847605     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Schairer, C., Lubin, J., Troisi, R., Sturgeon, S., Brinton, L., and Hoover, R. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. J. Am. Med. Assoc., 283: 485-491, 2000
2. Ross, R. K., Paganini-Hill, A., Wan, P, C., and Pike, M. C. Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin. J. Natl. Cancer Inst. (Bethesda), 92: 328-332, 2000
3. Colditz, G. A. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J. Natl. Cancer Inst. (Bethesda), 90: 814-823, 1998
4. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52.705 women with breast cancer and 108, 411 women without breast cancer. Lancet, 350: 1047-1059, 1997
5. Boyd, N. F., Lockwood, G. A., Byng, J. W., Tritchler, D. L., and Yaffe, M. J. Mammographic densities and breast cancer risk. Cancer Epidemiol. Biomark. Prev., 7: 1133-1144, 1998
6. Byrne, C., Schairer, C., Wolfe, J., Parekh, N., Salane, M., Brinton. L. A., Hoover, R., and Haile, R. Mammographic features and breast cancer risk: Effects with time, age, and menopause status. J. Natl. Cancer Inst. (Bethesda), 87: 1622-1629, 1995
7. Warner, E., Lockwood, G, Tritchler, D., and Boyd, N. F. The risk of breast cancer associated with mammographic parenchymal patterns: A meta-analysis of the published literature to examine the effect of method of classification. Cancer Detect. Prev., 16: 67-72, 1992
8. Greendale, G. A., Reboussin, B. A., Sie, A., Singh, R., Olson, L. K., Gatewood, O., Bassett, L. W., Wasilauska, C., Bush, T., and Barrett-Connor, E. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Ann. Intern. Med., 130: 262-269, 1999
9. Laya, M. B., Gallagher, J. C., Schreiman, J. S., Larson, E. B., Watson, P., and Weinstein, L. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology, 196: 433-437, 1995
10. Stomper, P. C., Van Voorhis, B. J., Ravnikar, V. A., and Meyer, J. E. Mammographic changes associated with postmenopausal hormone replacement therapy: A longitudinal study. Radiology, 174: 487-490, 1990
11. Marugg, R. C., van der Mooren, M. J., Hendriks, J. H., Rolland, R., and Ruijs, S. H. Mammographic changes in postmenopausal women on hormonal replacement therapy. Eur. Radiol., 7: 749-755, 1997
12. Cyrlak, D., and Wong, C. H. Mammographic changes in postmenopausal women undergoing hormonal replacement therapy. Am. J. Roentgenol., 161: 1177-1183, 1993
13. Rutter, C. M., Mandelson, M. T., Laya, M. B., Seger, D. J., and Taplin, S. Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. J. Am. Med. Assoc., 285: 171-176, 2001
14. Berkowitz, J. E., Gatewood, O. M. B., Goldblum, L. E., and Gayler, B. W. Hormonal replacement therapy; mammographic manifestations. Radiology, 174: 199-201, 1990
15. Kopans, D., D'Orsi, C., Adler, D., Bassett, L., Brenner, R., Dodd, G., Feig, S., Lopiano, M., McLelland, R., Moskowitz, M., and Sickles, E. American College of Radiology Breast Imaging and Reporting Data System (BI-RADS). Reston, VA: American College of Radiology, 1998
16. Byng, J. W., Boyd, N. F., Fishell, E., Jong, R. A., and Yaffe, M. J. The quantitative analysis of mammographic densities. Phys. Med. Biol., 39: 1629-1638, 1994
17. Byng, J. W., Boyd, N. F., Fishell, E., Jong, R. A., and Yaffe, M. J. Automated analysis of mammographic densities. Phys. Med. Biol., 41: 909-923, 1996
18. Wolfe, J. N. Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer (Phila.), 37: 1486-1492, 1976
19. Nagelkerke, N. A note on a general definition of the coefficient of determination. Biometrika, 78: 691-692, 1991
20. Lundstrom, E., Wilczek, B., von Palffy, Z., Soderqvist, G., and von Schoultz, B. Mammographic breast density during hormone replacement therapy: Differences according to treatment. Am. J. Obstet. Gynecol., 181: 348-352, 1999
21. Bergkvist, L., Adami, H. O., Persson, I., Hoover, R., and Schairer, C. The risk of breast cancer after estrogen and estrogen-progestin replacement. N. Engl. J. Med., 321: 293-297, 1989
22. Colditz. G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens. C., Rosner, B., and Speizer, F. E. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N. Engl. J. Med., 332: 1589-1593, 1995
23. Magnusson, C. M., Persson, I. R., Baron, J. A., Ekbom, A., Bergstrom, R., and Adami, H. O. The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50-74 years. Int. J. Cancer, 80: 231-236, 1999
24. Hofseth, L. J., Raafat, A. M., Osuch, J. R., Pathak, D. R., Slomski, C. A., and Haslam, S. Z. Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J. Clin. Endocrinol. Metab., 84: 4559-4565, 1999
25. Raafat, A. M., Li, S., Bennett, J. M., Hofseth, L. J., and Haslam, S. Z. Estrogen and estrogen plus progestin act directly on the mammary gland to increase proliferation in a postmenopausal mouse model., J. Cell. Physiol., 187: 81-89, 2001
26. Cline, J. M., Soderqvist, G., von Schoultz, E., Skoog, L., and von Schoultz. B. Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques. Am. J. Obstet. Gynecol., 174: 93-100, 1996
27. Soderqvist, G. Effects of sex steroids on proliferation in normal mammary tissue. Ann. Med., 30: 511-524, 1998
28. Ursin, G., Astrahan, M. A., Salane, M., Parisky, Y. R., Pearce, J. G., Daniels, J. R., Pike, M. C., and Spicer, D. V. The detection of changes in mammographic densities [published erratum appears in Cancer Epidemiol. Biomark. Prev., 7: 174, 1998]. Cancer Epidemiol. Biomark. Prev., 7: 43-47, 1998
29. Spicer, D. V., Ursin, G., Parisky, T., Pearce, J. G., Shoupe, D., Pike, A., and Pike, M. C. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J. Natl. Cancer Inst. (Bethesda), 86: 431-436, 1994
30. Ursin, G., Pike, M. C., Spicer, D. V., Porrath, S. A., and Reitherman, R. W. Can mammographic densities predict effects of tamoxifen on the breast? J. Natl. Cancer Inst. (Bethesda), 88: 128-129, 1996
31. Atkinson, C., Warren, R., Bingham, S. A., and Day, N. E. Mammographic patterns as a predictive biomarker of breast cancer risk: Effect of tamoxifen. Cancer Epidemiol. Biomark. Prev., 8: 863-866, 1999
32. Chow, C. K., Venzon, D., Jones, E. C., Premkumar, A., O'Shaughnessy, J., and Zujewski, J. Effect of tamoxifen on mammographic density. Cancer Epidemiol. Biomark. Prev., 9: 917-921, 2000
33. Son, H. J., and Oh, K. K. Significance of follow-up mammography in estimating the effect of tamoxifen in breast cancer patients who have undergone surgery. Am. J. Roentgenol., 173: 905-909, 1999
34. Vachon, C. M., Kushi, L. H., Cerhan, J. R., Kuni, C. C., and Sellers, T. A. Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. Cancer Epidemiol. Biomark. Prev., 9: 151-160, 2000